A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.

A novel class of potent direct 5-lipoxygenase (5-LO) inhibitors bearing a thiazolinone-scaffold identified by virtual screening is presented. A range of substitutions and the importance of the 2-phenyl moiety were evaluated. This series is characterized by high potency in intact polymorphonuclear leukocytes and a cell-free system, exemplified by (Z)-2-(4-chlorophenyl)-5-(4-methoxybenzylidene)-5H-thiazol-4-one (18, IC(50) = 0.28 and 0.09 μM). These disubstituted thiazolinones may possess potential for intervention with inflammatory and allergic diseases and certain cancer types.

[1]  E. Zayed,et al.  Studies on thiazolin-4-one: synthesis of some pyrano[2,3-b]-thiazole derivatives , 1985 .

[2]  J. Salmon,et al.  Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo , 1988, British journal of pharmacology.

[3]  Petra Schneider,et al.  Scaffold‐Hopping Cascade Yields Potent Inhibitors of 5‐Lipoxygenase , 2008, ChemMedChem.

[4]  Yvonne C. Martin,et al.  Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping , 2008, J. Chem. Inf. Model..

[5]  Y. Martin,et al.  Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.

[6]  Vladimir V Poroikov,et al.  Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. , 2008, Journal of medicinal chemistry.

[7]  S. Laufer,et al.  Stimulation of Suicidal Erythrocyte Death by Lipoxygenase Inhibitor Bay-Y5884 , 2006, Cellular Physiology and Biochemistry.

[8]  P. Selzer,et al.  Identification and Classification of GPCR Ligands Using Self‐Organizing Neural Networks , 2005 .

[9]  Andreas Zell,et al.  Locating Biologically Active Compounds in Medium-Sized Heterogeneous Datasets by Topological Autocorrelation Vectors: Dopamine and Benzodiazepine Agonists , 1996, J. Chem. Inf. Comput. Sci..

[10]  J. Bajorath,et al.  SAR index: quantifying the nature of structure-activity relationships. , 2007, Journal of medicinal chemistry.

[11]  O. Werz.  Inhibition of 5-Lipoxygenase Product Synthesis by Natural Compounds of Plant Origin , 2007, Planta medica.

[12]  R. D. Dyer,et al.  Synthesis and Biological Evaluation of 5-((3,5-Bis(1,1-dimethylethyl)- 4-hydroxyphenyl)methylene)oxazoles, -thiazoles, and -imidazoles: Novel Dual 5-Lipoxygenase and Cyclooxygenase Inhibitors with Antiinflammatory Activity. , 1994 .

[13]  C. Peng,et al.  Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia , 2009, Nature Genetics.

[14]  F. Olivieri,et al.  Lipoxygenase inhibitors for cancer prevention: promises and risks. , 2010, Current pharmaceutical design.

[15]  O. Werz,et al.  5-Lipoxygenase: regulation of expression and enzyme activity. , 2007, Trends in biochemical sciences.

[16]  O. Werz,et al.  Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. , 2002, Blood.

[17]  James G. Nourse,et al.  Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..

[18]  Oliver Werz,et al.  Therapeutic options for 5-lipoxygenase inhibitors. , 2006, Pharmacology & therapeutics.

[19]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[20]  B. Samuelsson,et al.  Microsomal prostaglandin E synthase‐1 and 5‐lipoxygenase: potential drug targets in cancer , 2010, Journal of internal medicine.

[21]  A. Noegel,et al.  Accelerated Clearance of Plasmodium-infected Erythrocytes in Sickle Cell Trait and Annexin-A7 Deficiency , 2009, Cellular Physiology and Biochemistry.

[22]  J. Bajorath,et al.  Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. , 2008, Journal of medicinal chemistry.